Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Amrallah A, Mohammed"'
Publikováno v:
Oncology Reviews, Vol 13, Iss 2 (2019)
Resistant to hormonal treatment considered the main clinical challenge in the management of advanced breast cancer (ABC). The use of CDK4/6 inhibitors (CDK4/6I) may change the treatment landscape. In this mandated review, we will focus on the applica
Externí odkaz:
https://doaj.org/article/0b9201e0cdba4c36892bca9c726d1cb8
Autor:
Amrallah A. Mohammed, Hani EL-Tanni, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Abdullah S. Al-Zahrani, Ayman EL-Shentenawy, Hani M. EL-Khatib
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 3, Pp 155-159 (2015)
Background: This study evaluates the correlation between body mass index (BMI) and clinicopathological parameters of metastatic prostate cancer (MPC) and its impact on survival. Method: During the study period, 71 MPC patients were eligible. Patients
Externí odkaz:
https://doaj.org/article/d46a28a70977407b9da6b12ff0a3a304
Autor:
Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Hafez M. Ghanem, Mian U. Farooq, Amr M. El Saify, Hani M. EL-Khatib
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 27, Iss 1, Pp 35-39 (2015)
Background: This study evaluates the use of palliative chemotherapy (PCT) and possible associated factors at the end of life. Method: The study includes all advanced non hematological cancer patients who died in the King Abdullah Medical City during
Externí odkaz:
https://doaj.org/article/ed1957b2bfd0462caebb1e276fe67e1c
Autor:
Reham A. Salem, Amrallah A. Mohammed
Publikováno v:
Forum of Clinical Oncology, Vol 12, Iss 1, Pp 22-30 (2021)
Background Growing evidence encourages the preventive role of vitamin D in pancreatic carcinoma (PC). Meanwhile, the prognostic or predictive role needs more investigations. This study aimed to evaluate the correlation between serum vitamin D levels
Autor:
Amrallah A. Mohammed, Abdullah S. Al-Zahrani, Mohamed A. Sherisher, Ahmad A. Alnagar, Ayman EL-Shentenawy, Amr T. El-Kashif
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 26, Iss 3, Pp 147-152 (2014)
Background: Although cancer patients are susceptible to infection, there is no evidence-based published guideline on the appropriate use of antimicrobial treatment in this group of patients. Methods: We retrospectively collected medical records of al
Externí odkaz:
https://doaj.org/article/8d6208f85961458387cd0f540b5ecb44
Publikováno v:
Forum of Clinical Oncology, Vol 12, Iss 1, Pp 31-38 (2021)
The heterogeneity of triple negative breast cancer (TNBC) is reflected in a bizarre response to therapy. Although it is chemotherapy sensitive, the failure is the usual pathway either in local or distance status. With progression in Gene Expression P
Publikováno v:
Forum of Clinical Oncology, Vol 11, Iss 3, Pp 9-16 (2021)
Background Desmoid tumors/aggressive fibromatosis (DTs/AF) are cytological bland fibrous neoplasms originating from the musculoaponeurotic structures throughout the body. The exact cause still remains unknown, however, they may present sporadically o
Autor:
Gamal Osman, Ahmed M. Elsayed, Walid S.H. Elsayed, Ola A. Harb, Adel Mahmoud Morsy, Ahmed A. Obaya, Amrallah A. Mohammed, Ahmed S Allam, Hanaa Rashied
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Despite the significant progress in target therapy for the treatment of metastatic colorectal carcinoma (mCRC), the overall survival isn’t satisfactory. Methods: We assessed the expression of Amphiregulin, PTEN, and P21 in sections from
Publikováno v:
Indian Journal of Palliative Care, Vol 27, Iss 1, Pp 43-46 (2021)
Indian Journal of Palliative Care
Indian Journal of Palliative Care
Background: For physicians and patients, survival estimation is vital for the treatment plan, especially with frequent use of new therapeutic agents in metastatic breast cancer (MBC). The Chuang's Prognostic Scale (CPS) is a validated prognostic scor
Autor:
Amrallah A. Mohammed, Hani EL-Tanni, Hani M. EL-Khatib, Ahmad A. Mirza, Abdulrahim A. Mirza, Turki H. Alturaifi
Publikováno v:
Oncology Reviews, Vol 10, Iss 2 (2016)
Currently, bladder cancer (BCa) evaluation depends mainly on traditional clinicopathological parameters encompassing tumor stage and grade, which will not reflect the behavior of the disease. Diverse molecular alterations are responsible for the hete
Externí odkaz:
https://doaj.org/article/aefd211961284b2689d84756aa542bb4